AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27704631 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 supplementation (3000 IU daily via oral spray)
Number of subjects: 42
Study 27704631 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study 26055947 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 797
Study 26055947 — intervention group
Group type: COMPARATOR
Intervention: Surgical bioprosthesis
Number of subjects: 797
Study 23353579 — intervention group
Group type: EXPERIMENTAL
Intervention: computerized cognitive behavioral therapy (cCBT) for insomnia
Number of subjects: 89
Study 21392105 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.02% epinephrine sprayed on the papilla
Number of subjects: 941
Study 21392105 — intervention group
Group type: COMPARATOR
Intervention: Saline sprayed on the papilla (control)
Number of subjects: 941
Study 20017627 — intervention group
Group type: EXPERIMENTAL
Intervention: Burst-firing pattern of weak (1 microTesla) magnetic fields
Number of subjects: 0
Study 20017627 — intervention group
Group type: EXPERIMENTAL
Intervention: Complex-sequenced pattern of weak (1 microTesla) magnetic fields
Number of subjects: 0
Study 20017627 — intervention group
Group type: EXPERIMENTAL
Intervention: Pattern whose electrical equivalents stimulate long-term potential in hippocampus slices
Number of subjects: 0
Study 20017627 — intervention group
Group type: COMPARATOR
Intervention: Sham field
Number of subjects: 0
Study 20017627 — intervention group
Group type: COMPARATOR
Intervention: Random-sequenced fields
Number of subjects: 0
Study 17626210 — intervention group
Group type: EXPERIMENTAL
Intervention: Cowhage
Number of subjects: 0
Study 17626210 — intervention group
Group type: EXPERIMENTAL
Intervention: Histamine
Number of subjects: 0
Study 17626210 — intervention group
Group type: COMPARATOR
Intervention: Topical Capsaicin
Number of subjects: 0
Study 17626210 — intervention group
Group type: COMPARATOR
Intervention: Antihistamine
Number of subjects: 0
Study 15174218 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBO)
Number of subjects: 71
Study 15174218 — intervention group
Group type: COMPARATOR
Intervention: Control (normal air)
Number of subjects: 71
Study 12226033 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin (400 mg once daily)
Number of subjects: 556
Study 12226033 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard oral treatment (amoxicillin, 1 g tid, or clarithromycin, 500 mg bid)
Number of subjects: 556
Study 12226033 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of moxifloxacin and standard oral treatment
Number of subjects: 556
Study 12226033 — intervention group
Group type: EXPERIMENTAL
Intervention: CAP-Sym questionnaire
Number of subjects: 556
Study 9839848 — intervention group
Group type: EXPERIMENTAL
Intervention: Running program (10 weeks)
Number of subjects: 38
Study 9839848 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 9839848 — intervention group
Group type: COMPARATOR
Intervention: Clomipramine
Number of subjects: 38
Study 9839848 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls (untrained)
Number of subjects: 38
Study 8073385 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose oral supplementation of alpha-tocopherol (825 mg daily), ascorbic acid (450 mg daily), and beta-carotene (45 mg daily) for three weeks prior to chemo- and radiotherapy.
Number of subjects: 22
Study 8073385 — intervention group
Group type: COMPARATOR
Intervention: No oral supplementation of antioxidants prior to chemo- and radiotherapy (control group).
Number of subjects: 22
Study 2643996 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine (2.5 mg/day)
Number of subjects: 30
Study 2643996 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 30972684 — intervention group
Group type: EXPERIMENTAL
Intervention: Sediment samples collected during summer and winter seasons; metals analyzed include Cd, Pb, Ni, Cu, Zn, Cr, As, Mn.
Number of subjects: 15
Study 30972684 — intervention group
Group type: EXPERIMENTAL
Intervention: Macrophytes sampled during summer and winter seasons; metals analyzed include Mn, As, Ni, Zn, Cr, Cd, Pb.
Number of subjects: 15
Study 30972684 — intervention group
Group type: EXPERIMENTAL
Intervention: Contamination degree (Cd) measured in lakes.
Number of subjects: 15
Study 30972684 — intervention group
Group type: EXPERIMENTAL
Intervention: Pollution load index calculated for lakes.
Number of subjects: 15
Study 30972684 — intervention group
Group type: EXPERIMENTAL
Intervention: PCA applied on sediment and macrophytes.
Number of subjects: 15
Study 28260235 — intervention group
Group type: EXPERIMENTAL
Intervention: Exenatide once-weekly (Bydureon™)
Number of subjects: 40
Study 28260235 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 24343457 — intervention group
Group type: EXPERIMENTAL
Intervention: Balneotherapy in addition to physiotherapy
Number of subjects: 46
Study 24343457 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy (exercise and transcutaneous electrical nerve stimulation)
Number of subjects: 46
Study 22111809 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral distal implants with ball abutments (retentive anchors)
Number of subjects: 48
Study 22111809 — intervention group
Group type: COMPARATOR
Intervention: Conventional mandibular partial dentures
Number of subjects: 48
Study 22111809 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral distal implants with healing caps
Number of subjects: 48
Study 21883197 — intervention group
Group type: EXPERIMENTAL
Intervention: onabotulinumtoxinA (155-195 U)
Number of subjects: 1384
Study 21883197 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 1384
Study 19401477 — intervention group
Group type: EXPERIMENTAL
Intervention: Community pharmacist-provided extended diabetes care service
Number of subjects: 78
Study 19401477 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study 16676893 — intervention group
Group type: EXPERIMENTAL
Intervention: Storytelling
Number of subjects: 42
Study 16676893 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducational information
Number of subjects: 42
Study 15346695 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-based intervention (comprehensive education, prescribed diet, intensive pharmacological therapy)
Number of subjects: 418
Study 15346695 — intervention group
Group type: COMPARATOR
Intervention: Control group (normally-discharged patients)
Number of subjects: 418
Study 15346695 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-based intervention
Number of subjects: 418
Study 15346695 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 418
Study 15346695 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 418
Study 11689579 — intervention group
Group type: EXPERIMENTAL
Intervention: Coordinated psychosocial interventions based on patient self-assessments
Number of subjects: 450
Study 11689579 — intervention group
Group type: COMPARATOR
Intervention: Standard care (control group)
Number of subjects: 450
Study 8994482 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT scanning with B pattern as positive
Number of subjects: 120
Study 8994482 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT scanning with B or C as positive
Number of subjects: 120
Study 8994482 — intervention group
Group type: EXPERIMENTAL
Intervention: SPECT scanning with B or C or D as positive
Number of subjects: 120
Study 8216656 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuity clinic exposure (10 students)
Number of subjects: 40
Study 8216656 — intervention group
Group type: COMPARATOR
Intervention: Non-continuity clinic exposure (30 students)
Number of subjects: 40
Study 3305080 — intervention group
Group type: EXPERIMENTAL
Intervention: Extended mastectomy (EM)
Number of subjects: 243
Study 3305080 — intervention group
Group type: COMPARATOR
Intervention: Radical mastectomy (RM)
Number of subjects: 243
Study 31870950 — intervention group
Group type: EXPERIMENTAL
Intervention: Emricasan 5 mg
Number of subjects: 263
Study 31870950 — intervention group
Group type: EXPERIMENTAL
Intervention: Emricasan 25 mg
Number of subjects: 263
Study 31870950 — intervention group
Group type: EXPERIMENTAL
Intervention: Emricasan 50 mg
Number of subjects: 263
Study 31870950 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 263
Study 31870950 — intervention group
Group type: EXPERIMENTAL
Intervention: Emricasan (all doses)
Number of subjects: 263
Study 29715354 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine with Propofol
Number of subjects: 173
Study 29715354 — intervention group
Group type: COMPARATOR
Intervention: Atropine with Atracurium and Sufentanil
Number of subjects: 173
Study 28188024 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic-assisted gait training therapy (RAGT) using Lokomat®Pediatric, 20 sessions
Number of subjects: 30
Study 28188024 — intervention group
Group type: COMPARATOR
Intervention: Control Group receiving only daily physiotherapy
Number of subjects: 30
Study 25156528 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Internet plus phone (proactive telephone counseling)
Number of subjects: 1236
Study 25156528 — intervention group
Group type: EXPERIMENTAL
Intervention: Enhanced Internet (online social network)
Number of subjects: 1236
Study 25156528 — intervention group
Group type: COMPARATOR
Intervention: Basic Internet (static Internet comparison condition)
Number of subjects: 1236
Study 23300153 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher cystatin C levels (quartile 4)
Number of subjects: 4709
Study 23300153 — intervention group
Group type: COMPARATOR
Intervention: Serum creatinine and creatinine-based estimated glomerular filtration rate (eGFRCr)
Number of subjects: 4709
Study 21196773 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted semitailored intervention programme (counselling programme, teaching courses, written information, logbooks)
Number of subjects: 330
Study 21196773 — intervention group
Group type: COMPARATOR
Intervention: Follow-up only (control group)
Number of subjects: 330
Study 18056755 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab 40 mg every other week
Number of subjects: 315
Study 18056755 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab after 1 year
Number of subjects: 315
Study 18056755 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab after 2 years
Number of subjects: 315
Study 18056755 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 315
Study 17156168 — intervention group
Group type: EXPERIMENTAL
Intervention: AUDIT total score (8-15, 16-19, 20-40)
Number of subjects: 1335
Study 17156168 — intervention group
Group type: EXPERIMENTAL
Intervention: AUDIT zone with scores of 20 and above
Number of subjects: 1335
Study 12771973 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (4 g daily)
Number of subjects: 44
Study 12771973 — intervention group
Group type: COMPARATOR
Intervention: Corn oil (4 g daily)
Number of subjects: 44
Study 12771973 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil
Number of subjects: 44
Study 12771973 — intervention group
Group type: COMPARATOR
Intervention: Corn oil
Number of subjects: 44
Study 10685811 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational lifting of 25 kg in the individual's first job
Number of subjects: 114
Study 10685811 — intervention group
Group type: EXPERIMENTAL
Intervention: Occupational lifting of 50 kg in their main job
Number of subjects: 114
Study 10685811 — intervention group
Group type: EXPERIMENTAL
Intervention: Spending > 2 h each day sitting during their first job
Number of subjects: 114
Study 10685811 — intervention group
Group type: COMPARATOR
Intervention: Obesity (highest vs lowest thirds of distribution of body mass index)
Number of subjects: 114
Study 9474428 — intervention group
Group type: EXPERIMENTAL
Intervention: Sliding screw plate and a parallel cancellous screw (SSP)
Number of subjects: 225
Study 9474428 — intervention group
Group type: COMPARATOR
Intervention: Two Olmed screws
Number of subjects: 225
Study 8174729 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.6 mM pentoxifylline alone
Number of subjects: 121
Study 8174729 — intervention group
Group type: EXPERIMENTAL
Intervention: 3.0 mM 2‐deoxyadenosine combined with 3.6 mM pentoxifylline
Number of subjects: 121
Study 8174729 — intervention group
Group type: COMPARATOR
Intervention: Control sperm preparation
Number of subjects: 121
Study 8174729 — intervention group
Group type: EXPERIMENTAL
Intervention: Treated sperm preparations
Number of subjects: 121
Study 8174729 — intervention group
Group type: EXPERIMENTAL
Intervention: Sperm stimulation
Number of subjects: 121
Study 3356086 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 26
Study 3356086 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 26
Study 3356086 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 30361757 — intervention group
Group type: EXPERIMENTAL
Intervention: Uncemented fixation with titanium fiber mesh coating
Number of subjects: 41
Study 30361757 — intervention group
Group type: COMPARATOR
Intervention: Cemented fixation
Number of subjects: 41
Study 28533194 — intervention group
Group type: EXPERIMENTAL
Intervention: Volatile anesthetic
Number of subjects: 10600
Study 28533194 — intervention group
Group type: COMPARATOR
Intervention: Total intravenous anesthesia
Number of subjects: 10600
Study 25867743 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote limb ischemic conditioning (RLIC)
Number of subjects: 18
Study 25867743 — intervention group
Group type: COMPARATOR
Intervention: Sham conditioning
Number of subjects: 18
Study 23276549 — intervention group
Group type: EXPERIMENTAL
Intervention: Adalimumab
Number of subjects: 16
Study 23276549 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 21056414 — intervention group
Group type: EXPERIMENTAL
Intervention: Husband/partner present during labor
Number of subjects: 197
Study 21056414 — intervention group
Group type: COMPARATOR
Intervention: No husband/partner present during labor
Number of subjects: 197
Study 17945197 — intervention group
Group type: EXPERIMENTAL
Intervention: Selective serotonin reuptake inhibitor (SSRI) citalopram
Number of subjects: 51
Study 17945197 — intervention group
Group type: EXPERIMENTAL
Intervention: Substance P (SP) antagonist CP-96345
Number of subjects: 51
Study 17945197 — intervention group
Group type: COMPARATOR
Intervention: Glucocorticoid antagonist RU486
Number of subjects: 51
Study 16546279 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomotherapy (TOMO-a)
Number of subjects: 5
Study 16546279 — intervention group
Group type: EXPERIMENTAL
Intervention: Tomotherapy (TOMO-b)
Number of subjects: 5
Study 16546279 — intervention group
Group type: COMPARATOR
Intervention: IMRT
Number of subjects: 5
Study 12921879 — intervention group
Group type: EXPERIMENTAL
Intervention: Live Lactobacillus johnsonii La1
Number of subjects: 326
Study 12921879 — intervention group
Group type: COMPARATOR
Intervention: Heat-killed Lactobacillus johnsonii La1
Number of subjects: 326
Study 12921879 — intervention group
Group type: COMPARATOR
Intervention: Live Lactobacillus paracasei ST11
Number of subjects: 326
Study 12921879 — intervention group
Group type: COMPARATOR
Intervention: Heat-killed Lactobacillus paracasei ST11
Number of subjects: 326
Study 12921879 — intervention group
Group type: COMPARATOR
Intervention: Vehicle (control group)
Number of subjects: 326
Study 12796071 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity exercise for 16 months
Number of subjects: 131
Study 12796071 — intervention group
Group type: COMPARATOR
Intervention: Control group (sedentary)
Number of subjects: 131
Study 10195530 — intervention group
Group type: EXPERIMENTAL
Intervention: Sameridine 15 mg
Number of subjects: 140
Study 10195530 — intervention group
Group type: EXPERIMENTAL
Intervention: Sameridine 20 mg
Number of subjects: 140
Study 10195530 — intervention group
Group type: EXPERIMENTAL
Intervention: Sameridine 23 mg
Number of subjects: 140
Study 10195530 — intervention group
Group type: COMPARATOR
Intervention: Lidocaine 100 mg
Number of subjects: 140
Study 8897012 — intervention group
Group type: EXPERIMENTAL
Intervention: GLP-1 (50 pmol.kg‐1.h‐1) infusion
Number of subjects: 7
Study 8897012 — intervention group
Group type: COMPARATOR
Intervention: 154 mmol/l NaCl (placebo) infusion
Number of subjects: 7
Study 10146956 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ofloxacin
Number of subjects: 126
Study 10146956 — intervention group
Group type: COMPARATOR
Intervention: Standard parenteral therapy
Number of subjects: 126
Study 6094455 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefotaxime 1.0 g
Number of subjects: 1500
Study 6094455 — intervention group
Group type: COMPARATOR
Intervention: Cefuroxime 1.5 g
Number of subjects: 1500
Study 3534018 — intervention group
Group type: EXPERIMENTAL
Intervention: Tretinoin
Number of subjects: 0
Study 3534018 — intervention group
Group type: EXPERIMENTAL
Intervention: Motretinide
Number of subjects: 0
Study 3534018 — intervention group
Group type: COMPARATOR
Intervention: Systemic administration of etretinate
Number of subjects: 0
Study 3534018 — intervention group
Group type: EXPERIMENTAL
Intervention: A-scan ultrasound and laser Doppler flowmetry
Number of subjects: 0
Study 30922323 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab plus paclitaxel (switch maintenance)
Number of subjects: 0
Study 30922323 — intervention group
Group type: COMPARATOR
Intervention: Continuation of first-line therapy with oxaliplatin/fluoropyrimidine (control)
Number of subjects: 0
Study 28488380 — intervention group
Group type: EXPERIMENTAL
Intervention: Capox (oxaliplatin 60 mg/m2 weekly with capecitabine 825 mg/m2 twice daily)
Number of subjects: 63
Study 28488380 — intervention group
Group type: COMPARATOR
Intervention: Cap (capecitabine 825 mg/m2 twice daily)
Number of subjects: 63
Study 28488380 — intervention group
Group type: EXPERIMENTAL
Intervention: Capox
Number of subjects: 63
Study 28488380 — intervention group
Group type: COMPARATOR
Intervention: Cap
Number of subjects: 63
Study 25332100 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin (425 mg/d) for 24 months
Number of subjects: 23
Study 25332100 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 23
Study 23968892 — intervention group
Group type: EXPERIMENTAL
Intervention: CBTpA+SC
Number of subjects: 30
Study 23968892 — intervention group
Group type: EXPERIMENTAL
Intervention: FIpA+SC
Number of subjects: 30
Study 23968892 — intervention group
Group type: COMPARATOR
Intervention: SC alone
Number of subjects: 30
Study 21503849 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual insertion of mini-implants after pre-drilling with a dental handpiece
Number of subjects: 30
Study 21503849 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-drilling mini-implants inserted without pre-drilling
Number of subjects: 30
Study 21503849 — intervention group
Group type: EXPERIMENTAL
Intervention: Injection of local anesthetic next to the insertion region
Number of subjects: 30
Study 21503849 — intervention group
Group type: COMPARATOR
Intervention: Standard injection methods
Number of subjects: 30
Study 19222849 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum CRP in NAFLD (simple steatosis and steatohepatitis)
Number of subjects: 100
Study 19222849 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum PCT in NAFLD (simple steatosis and steatohepatitis)
Number of subjects: 100
Study 19222849 — intervention group
Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 100
Study 17053867 — intervention group
Group type: EXPERIMENTAL
Intervention: Flap repair with fibrin glue
Number of subjects: 58
Study 17053867 — intervention group
Group type: COMPARATOR
Intervention: Flap repair alone
Number of subjects: 58
Study 15815074 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic subjects
Number of subjects: 0
Study 15815074 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 2 diabetic subjects with complications
Number of subjects: 0
Study 15815074 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 0
Study 11483264 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP‐IPV/Hib (mix)
Number of subjects: 400
Study 9256585 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-assisted social skills training program (12 sessions); stimulant medication prescribed for all children with ADHD.
Number of subjects: 49
Study 9256585 — intervention group
Group type: COMPARATOR
Intervention: Waitlist group (no treatment during the study period).
Number of subjects: 49
Study 8500318 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical ophthalmic medications (specific medications not detailed)
Number of subjects: 320
Study 8500318 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 320
Study 3436982 — intervention group
Group type: EXPERIMENTAL
Intervention: Passive exercise
Number of subjects: 6
Study 3436982 — intervention group
Group type: COMPARATOR
Intervention: Static wrapping
Number of subjects: 6
Study 31736328 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 4744
Study 31736328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4744
Study 29277839 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation in SCFG (n = 22)
Number of subjects: 78
Study 29277839 — intervention group
Group type: EXPERIMENTAL
Intervention: Synbiotic supplementation in SCFG with positive bacteriology (n = 10)
Number of subjects: 78
Study 29277839 — intervention group
Group type: COMPARATOR
Intervention: Placebo in PCFG (n = 19)
Number of subjects: 78
Study 29277839 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG, n = 17)
Number of subjects: 78
Study 27450419 — intervention group
Group type: EXPERIMENTAL
Intervention: Sulforaphane (SFN) supplementation with broccoli sprout homogenate
Number of subjects: 0
Study 25703254 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg estradiol plus 0.5 mg noretisterone acetate (NETA)
Number of subjects: 100
Study 25703254 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg drospirenone (DRSP)
Number of subjects: 100
Study 25703254 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 23010419 — intervention group
Group type: EXPERIMENTAL
Intervention: High Calcium Diet (HCD; 1200-1300 mg/d)
Number of subjects: 35
Study 23010419 — intervention group
Group type: COMPARATOR
Intervention: Low Calcium Diet (LCD; <500 mg/d)
Number of subjects: 35
Study 20172742 — intervention group
Group type: COMPARATOR
Intervention: Percutaneous endoscopic gastrostomy (PEG)
Number of subjects: 40
Study 20172742 — intervention group
Group type: EXPERIMENTAL
Intervention: Percutaneous radiologic gastrostomy (PRG)
Number of subjects: 40